Literature DB >> 21282990

The New Zealand National Eye Bank: survival and visual outcome 1 year after penetrating keratoplasty.

Hussain Y Patel1, Sue Ormonde, Nigel H Brookes, S Louise Moffatt, Trevor Sherwin, David G C Pendergrast, Charles N J McGhee.   

Abstract

PURPOSE: To identify potential donor, recipient, surgical, and postoperative factors that may influence survival and visual outcome of penetrating keratoplasty (PKP).
METHODS: As part of a prospective longitudinal study, the electronic records of the New Zealand National Eye Bank were analyzed for the 10-year period from 1994-2003. Both univariate and multivariate analysis was performed.
RESULTS: During the study period, the New Zealand National Eye Bank supplied 1820 corneas for PKP and 1629 (90%) had 1-year follow-up data. Overall, the 1-year survival rate was 87% (n = 1429). Donor factors including age, donor source, cause of death, death-to-preservation interval, endothelial cell density, donor lens status, and storage duration, were not significantly associated with decreased survival. The leading cause of PKP failure was irreversible rejection (7%, n = 114). Independent risk factors identified for decreased PKP survival were: 1 or more episodes of reversible rejection, active inflammation at PKP, preexisting corneal vascularization, intraoperative complications, small graft size (≤ 7.25 mm), large graft size (≥ 8.5 mm), preoperative glaucoma, and a preoperative diagnosis of regraft or trauma. A best-corrected Snellen visual acuity of 6/12 or better was achieved in 60% of eyes [mean: 6/15 (logarithm of the minimum angle of resolution 0.40)]. Keratoconus and Fuchs endothelial dystrophy were the diagnoses with best survival and visual outcome, whereas, bullous keratopathy, trauma or noninfective keratitis were associated with poorer visual outcome.
CONCLUSIONS: Several independent risk factors were identified that significantly influenced PKP first year survival outcome. This information is valuable to patients and surgeons with respect to determining prognosis and clinical decision making.

Entities:  

Mesh:

Year:  2011        PMID: 21282990     DOI: 10.1097/ICO.0b013e3182014668

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  Glaucoma in penetrating keratoplasty: risk factors, management and outcome.

Authors:  Klaudia K Huber; Anna-Karina B Maier; Matthias K J Klamann; Jessica Rottler; Sevil Özlügedik; Katja Rosenbaum; Johannes Gonnermann; Sibylle Winterhalter; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-30       Impact factor: 3.117

2.  Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival.

Authors:  Romina Fasciani; Luigi Mosca; Maria Ilaria Giannico; Simone Antonio Ambrogio; Emilio Balestrazzi
Journal:  Int Ophthalmol       Date:  2014-04-09       Impact factor: 2.031

3.  Comparative cost-effectiveness analysis of descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States.

Authors:  Shreya S Prabhu; Rola Kaakeh; Alan Sugar; Dean G Smith; Roni M Shtein
Journal:  Am J Ophthalmol       Date:  2012-09-08       Impact factor: 5.258

4.  Intraocular pressure elevation and post-DSEK glaucoma after Descemet`s stripping endothelial keratoplasty.

Authors:  Anna-Karina B Maier; Matthias K J Klamann; Necip Torun; Johannes Gonnermann; Jan Schroeter; Antonia M Joussen; Peter Rieck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-20       Impact factor: 3.117

5.  [Corneal transplantation: study carried out at the Department of Ophthalmology, University Hospital Center Mohammed VI, Marrakech].

Authors:  Sarah Belghmaidi; Ibtissam Hajji; Hasna Soummane; Wiam Ennassiri; Hafsa Essafi; Abdeljalil Moutaouakil
Journal:  Pan Afr Med J       Date:  2016-04-06

6.  Factors associated with endothelial cell density loss post Descemet membrane endothelial keratoplasty for bullous keratopathy in Asia.

Authors:  Satoru Inoda; Takahiko Hayashi; Hidenori Takahashi; Itaru Oyakawa; Hideaki Yokogawa; Akira Kobayashi; Naoko Kato; Hidetoshi Kawashima
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

7.  Evaluation of the Clinical Findings of Patients with Penetrating Keratoplasty Followed by Telephone Due to the COVID-19 Pandemic

Authors:  Semir Yarımada; Özlem Barut Selver; Melis Palamar
Journal:  Turk J Ophthalmol       Date:  2022-04-28

8.  Endothelial failure and rejection in recipients of corneas from the same donor.

Authors:  Lewis Downward; Mahmoud Ahmed; Cathy Hopkinson; Vito Romano; Elinor Curnow; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-08

9.  Screening the visual system homeobox 1 gene in keratoconus and posterior polymorphous dystrophy cohorts identifies a novel variant.

Authors:  Andrea L Vincent; Charlotte Jordan; Leo Sheck; Rachel Niederer; Dipika V Patel; Charles N J McGhee
Journal:  Mol Vis       Date:  2013-04-11       Impact factor: 2.367

10.  Self-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study.

Authors:  Han Y Yin; Anny M S Cheng; Sean Tighe; Philip Kurochkin; Jamie Nord; Swetha Dhanireddy; Robert Swan; Samuel Alpert
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.